bso inhibition glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression: Cancer Cell Effective treatment of advanced solid

A parallel trial conducted at Stanford and published in Cell Metabolism in March 2026 found that patients with NAFLD (non-alcoholic fatty liver disease) who supplemented with N-acetylcysteine (NAC, a glutathione precursor) alongside GLP-1 therapy achieved 73% NASH resolution versus 59% on medication alone

These findings implicate CHAC2 in various cellular functions, including DNA replication and repair, cell cycle regulation, apoptosis, and stem cell differentiation, indicating that its functional repertoire is more versatile than initially presumed (Peng et al., 2023

Googles own AI Overview reflects this balanced view which is exactly the kind of honest framing that builds trust and rankings on this topic

Battaglia, A